Zobrazeno 1 - 5
of 5
pro vyhledávání: '"David C D Hope"'
Autor:
Neil E Hill, Nick S Oliver, Wei Yang, Christine Shi, Chioma Izzi-Engbeaya, Walter Distaso, Anjali Amin, Oluwagbemiga Idowu, Julia S Kenkre, Ronak J Shah, Evelina Woin, Nael Alavi, Hala Bedri, Niamh Brady, Sophie Blackburn, Martina Leczycka, Sanya Patel, Elizaveta Sokol, Edward Toke-Bjolgerud, Ambreen Qayum, Mariana Abdel-Malek, David C D Hope, Vasiliki Bravis, Tricia M Tan, Victoria Salem
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
Introduction Patients with diabetes mellitus admitted to hospital with COVID-19 have poorer outcomes. However, the drivers of poorer outcomes are not fully elucidated. We performed detailed characterization of patients with COVID-19 to determine the
Externí odkaz:
https://doaj.org/article/7eb1ab04c8e4484f83b7fe832907e545
Autor:
Charlotte E. Hinds, Bryn M. Owen, David C. D. Hope, Philip Pickford, Ben Jones, Tricia M. Tan, James S. Minnion, Stephen R. Bloom
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Glucagon receptor agonists show promise as components of next generation metabolic syndrome pharmacotherapies. However, the biology of glucagon action is complex, controversial, and likely context dependent. As such, a better understanding o
Externí odkaz:
https://doaj.org/article/8c5c2844790d4fd68305731ce059ecb1
Autor:
Emma Rose McGlone, Matthieu Siebert, Marian Dore, David C. D. Hope, Iona Davies, Bryn Owen, Bernard Khoo, Rob Goldin, Dave Carling, Stephen Bloom, Maude Le Gall, Tricia M‐M. Tan
Publikováno v:
Liver International.
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2018)
Over the last century, our knowledge of the processes which control appetite and weight regulation has developed significantly. The understanding of where gut hormones fit into the control of energy homeostasis in addition to the rapid advancement of
Externí odkaz:
https://doaj.org/article/d43c8265b7f04bf0adce7f5cbbb4384f
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Obesity and Type 2 diabetes represent global health challenges, and there is an unmet need for long-lasting and effective pharmacotherapies. Although long-acting glucagon-like peptide-1 (GLP-1) analogues are now in routine use for diabetes and are no
Externí odkaz:
https://doaj.org/article/4f288b63e859423b8242bb6d07b4cc97